GlassScriptPhysician profile
Lea Collier Pisching
NPI 1568015121
$15,442.29
in general payments reported to CMS, 2019-2025
32 companies · $3,683 in 2025
The $3,683 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,169 · 2022: $2,897 · 2023: $3,286 · 2024: $3,407 · 2025: $3,683.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Education: $352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,024.50 |
| Education | $351.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,598.08 | 2021-2025 | |
| Janssen Biotech, INC. | $1,817.97 | 2021-2025 | Tremfya |
| Incyte Corporation | $1,162.48 | 2021-2025 | Opzelura, Opzelura, Iclusig |
| Sun Pharmaceutical Industries INC. | $1,059.52 | 2021-2025 | Ilumya, Winlevi |
| Novartis Pharmaceuticals Corporation | $896.46 | 2021-2025 | |
| Leo Pharma INC. | $865.80 | 2022-2025 | Adbry, Spevigo |
| Regeneron Healthcare Solutions, INC. | $799.58 | 2021-2025 | Dupixent, Libtayo |
| E.R. Squibb & Sons, L.L.C. | $694.07 | 2022-2025 | Sotyktu |
| Arcutis Biotherapeutics, INC. | $676.35 | 2023-2025 | Zoryve |
| Lilly USA, LLC | $588.21 | 2021-2025 | Taltz, Olumiant, Ebglyss |
| Galderma Laboratories, L.P. | $510.75 | 2021-2025 | Aklief, Epsolay, Nemluvio |
| Amgen INC. | $506.15 | 2021-2025 | Otezla, Otezla |
| Genzyme Corporation | $453.09 | 2021-2025 | |
| Ucb, INC. | $434.69 | 2021-2025 | Bimzelx |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $253.76 | 2021-2025 | Cabtreo, Jublia, Arazlo |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $185.97 | 2023-2025 | Tremfya |
| Dermavant Sciences, INC. | $164.79 | 2022-2024 | Vtama |
| Verrica Pharmaceuticals INC. | $161.25 | 2024 | Ycanth |
| Pfizer INC. | $110.02 | 2021-2022 | |
| Helsinn Therapeutics (U.S.), INC. | $108.40 | 2022-2024 | Valchlor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $91.14 | 2022-2025 | Spevigo |
| Biofrontera INC. | $56.00 | 2024-2025 | Rhodoled Xl, Ameluz, Xepi |
| Allergan, INC. | $39.84 | 2021-2022 | |
| Organon LLC | $37.83 | 2025 | Nexplanon |
| Vyne Pharmaceuticals INC. | $37.34 | 2021 | |
| Lnhc, INC | $24.70 | 2025 | Zelsuvmi |
| Kyowa Kirin, INC. | $23.66 | 2022 | |
| Nobelpharma America, LLC | $19.72 | 2025 | |
| Mayne Pharma Commercial LLC | $16.62 | 2021 | |
| Fresenius Kabi USA, LLC | $16.38 | 2024 | Idacio |
| Botanix Sb INC | $15.95 | 2025 | Sofdra |
| Epi Health, LLC | $15.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lea Pisching listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.